ImmunityBio Inc (NASDAQ: IBRX) is 1.59% higher on its value in year-to-date trading and has touched a low of $3.10 and a high of $10.53 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The IBRX stock was last observed hovering at around $5.03 in the last trading session, with the day’s gains setting it 0.07%.
Currently trading at $5.10, the stock is -2.67% and 19.42% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.42 million and changing 1.29% at the moment leaves the stock -3.36% off its SMA200. IBRX registered 21.72% gain for a year compared to 6-month loss of -21.78%. The firm has a 50-day simple moving average (SMA 50) of $4.2708 and a 200-day simple moving average (SMA200) of $5.277375.
The stock witnessed a 21.14% gain in the last 1 month and extending the period to 3 months gives it a 21.14%, and is 13.59% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.61% over the week and 13.09% over the month.
ImmunityBio Inc (IBRX) has around 628 employees, a market worth around $3.60B and $7.33M in sales. Profit margin for the company is -8016.83%. Distance from 52-week low is 64.52% and -51.57% from its 52-week high. The company has generated returns on investments over the last 12 months (-222.32%).
with sales reaching $9.07M over the same period.The EPS is expected to grow by 27.54% this year, but quarterly earnings will post 3,745.87% year-over-year. Quarterly sales are estimated to grow 6,425.90% in year-over-year returns.
ImmunityBio Inc (IBRX) Top Institutional Holders
254.0 institutions hold shares in ImmunityBio Inc (IBRX), with institutional investors hold 43.99% of the company’s shares. The shares outstanding are 670.87M, and float is at 159.58M with Short Float at 33.06%. Institutions hold 10.12% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 13.83 million shares valued at $87.42 million. The investor’s holdings represent 2.0558% of the IBRX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.42 million shares valued at $72.19 million to account for 1.6978 of the shares outstanding. The other top investors are STATE STREET CORP which holds 7.86 million shares representing 1.1688% and valued at over $49.7 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.5822 of the shares totaling 3.92 million with a market value of $24.76 million.
ImmunityBio Inc (IBRX) Insider Activity
#####
